Chitosan, a versatile biopolymer derived from chitin, is already a well-established player in pharmaceuticals, medicine, cosmetics, and environmental applications. But things get even more interesting when chitosan joins forces with another powerful compound: caffeine. While it might sound like the base of a high-energy supplement, this combination is in fact a promising area of research – with applications reaching far beyond the food industry.

Nanocomposites with antioxidant properties are gaining increasing importance in biomedical and particularly dental research. These materials combine conventional substances with nano-particles, aiming to enhance mechanical, chemical, or biological performance. [1]

As a successful example of startup-driven growth and translation in the Halle life science ecosystem, HMC will join forces with the Start-up PerioTrap Pharmaceuticals, showcasing how deep science, strong partnerships and smart location development create global impact.

The review article presents various chitosan-based platforms for drug delivery. In particular, systems for cancer treatment and for the delivery of growth factors that promote tissue regeneration.